Selectivity on-target of bromodomain chemical probes by structure-guided medicinal chemistry and chemical biology

Carles Galdeano, Alessio Ciulli (Lead / Corresponding author)

Research output: Contribution to journalArticle

29 Citations (Scopus)
496 Downloads (Pure)

Abstract

Targeting epigenetic proteins is a rapidly growing area for medicinal chemistry and drug discovery. Recent years have seen an explosion of interest in developing small molecules binding to bromodomains, the readers of acetyl-lysine modifications. A plethora of co-crystal structures has motivated focused fragment-based design and optimization programs within both industry and academia. These efforts have yielded several compounds entering the clinic, and many more are increasingly being used as chemical probes to interrogate bromodomain biology. High selectivity of chemical probes is necessary to ensure biological activity is due to an on-target effect. Here, we review the state-of-the-art of bromodomain-targeting compounds, focusing on the structural basis for their on-target selectivity or lack thereof. We also highlight chemical biology approaches to enhance on-target selectivity.

Original languageEnglish
Pages (from-to)1655-1680
Number of pages26
JournalFuture Medicinal Chemistry
Volume8
Issue number13
Early online date19 May 2016
DOIs
Publication statusPublished - Sep 2016

Fingerprint

Pharmaceutical Chemistry
Explosions
Protein Transport
Drug Discovery
Epigenomics
Lysine
Industry

Keywords

  • BET bromodomains
  • chemical genetics
  • chemical probes
  • selectivity
  • structure-based drug discovery

Cite this

@article{8f5088b888a340d58586558651b6cf5c,
title = "Selectivity on-target of bromodomain chemical probes by structure-guided medicinal chemistry and chemical biology",
abstract = "Targeting epigenetic proteins is a rapidly growing area for medicinal chemistry and drug discovery. Recent years have seen an explosion of interest in developing small molecules binding to bromodomains, the readers of acetyl-lysine modifications. A plethora of co-crystal structures has motivated focused fragment-based design and optimization programs within both industry and academia. These efforts have yielded several compounds entering the clinic, and many more are increasingly being used as chemical probes to interrogate bromodomain biology. High selectivity of chemical probes is necessary to ensure biological activity is due to an on-target effect. Here, we review the state-of-the-art of bromodomain-targeting compounds, focusing on the structural basis for their on-target selectivity or lack thereof. We also highlight chemical biology approaches to enhance on-target selectivity.",
keywords = "BET bromodomains, chemical genetics, chemical probes, selectivity, structure-based drug discovery",
author = "Carles Galdeano and Alessio Ciulli",
year = "2016",
month = "9",
doi = "10.4155/fmc-2016-0059",
language = "English",
volume = "8",
pages = "1655--1680",
journal = "Future Medicinal Chemistry",
issn = "1756-8919",
publisher = "Future Science Group",
number = "13",

}

TY - JOUR

T1 - Selectivity on-target of bromodomain chemical probes by structure-guided medicinal chemistry and chemical biology

AU - Galdeano, Carles

AU - Ciulli, Alessio

PY - 2016/9

Y1 - 2016/9

N2 - Targeting epigenetic proteins is a rapidly growing area for medicinal chemistry and drug discovery. Recent years have seen an explosion of interest in developing small molecules binding to bromodomains, the readers of acetyl-lysine modifications. A plethora of co-crystal structures has motivated focused fragment-based design and optimization programs within both industry and academia. These efforts have yielded several compounds entering the clinic, and many more are increasingly being used as chemical probes to interrogate bromodomain biology. High selectivity of chemical probes is necessary to ensure biological activity is due to an on-target effect. Here, we review the state-of-the-art of bromodomain-targeting compounds, focusing on the structural basis for their on-target selectivity or lack thereof. We also highlight chemical biology approaches to enhance on-target selectivity.

AB - Targeting epigenetic proteins is a rapidly growing area for medicinal chemistry and drug discovery. Recent years have seen an explosion of interest in developing small molecules binding to bromodomains, the readers of acetyl-lysine modifications. A plethora of co-crystal structures has motivated focused fragment-based design and optimization programs within both industry and academia. These efforts have yielded several compounds entering the clinic, and many more are increasingly being used as chemical probes to interrogate bromodomain biology. High selectivity of chemical probes is necessary to ensure biological activity is due to an on-target effect. Here, we review the state-of-the-art of bromodomain-targeting compounds, focusing on the structural basis for their on-target selectivity or lack thereof. We also highlight chemical biology approaches to enhance on-target selectivity.

KW - BET bromodomains

KW - chemical genetics

KW - chemical probes

KW - selectivity

KW - structure-based drug discovery

U2 - 10.4155/fmc-2016-0059

DO - 10.4155/fmc-2016-0059

M3 - Article

C2 - 27193077

VL - 8

SP - 1655

EP - 1680

JO - Future Medicinal Chemistry

JF - Future Medicinal Chemistry

SN - 1756-8919

IS - 13

ER -